Enovix Corp — Director's Dealing 2021

Jul 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enovix Corp (ENVX)
CIK: 0001828318
Period of Report: 2021-07-14

Reporting Person: Pietzke Steffen (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	276918	Acquired	2031-04-19	Common Stock (276918)	Direct
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	71020	Acquired	2031-04-19	Common Stock (71020)	Direct
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	369226	Acquired	2031-04-19	Common Stock (369226)	Direct

Footnotes

F1: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.

F2: The shares subject to the option are immediately exercisable. 1/5th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 18, 2021, and 1/60th of the shares subject to the option will vest in 48 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F3: Received in exchange for a stock option to purchase 1,500,000 shares of Legacy Enovix Common Stock.

F4: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.

F5: Received in exchange for a stock option to purchase 384,700 shares of Legacy Enovix Common Stock.

F6: The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 1, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F7: Received in exchange for a stock option to purchase 2,000,000 shares of Legacy Enovix Common Stock.